Pictured: Jedd Wolchok and James Allison
In the News
By Media Staff  |  Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Pictured: James Eastham
Video
By Memorial Sloan-Kettering  |  Monday, April 16, 2012

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Pictured: Bruce
Patient Story
By Memorial Sloan-Kettering  |  Monday, April 9, 2012

A routine blood test led to a diagnosis of bone cancer for Bruce, an otherwise healthy 43-year-old writer. Surgeons at Memorial Sloan-Kettering removed his cancer and saved his leg, giving him the chance to resume his career as “the writer who walks.”

Pictured: T cells on surface on thymus
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, April 6, 2012

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Pictured: Yuman Fong
Video
By Memorial Sloan-Kettering  |  Thursday, April 5, 2012

Yuman Fong, Memorial Sloan-Kettering’s Vice Chair of Technology Development and a surgeon who treats patients with liver, bile duct, gallbladder, and pancreas diseases, talks about surgical advances that improve outcomes for patients.

Pictured: American Association of Cancer Research Annual Meeting 2012
Announcement
By Media Staff  |  Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Pictured: Sergio Giralt
Q&A
By Memorial Sloan-Kettering  |  Monday, March 26, 2012

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

Pictured: Elizabeth Morris
In the O.R.
By Esther Napolitano, BS and Allyson Collins, MS
Friday, March 16, 2012

Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Pictured: Ross Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Pictured: Peter Scardino
Q&A
By Memorial Sloan-Kettering  |  Monday, March 12, 2012

Department of Surgery Chair Peter T. Scardino reflects on the expanding role of surgery at an institution devoted to caring for people with cancer.

Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Pictured: Mark Bilsky
Q&A
By Memorial Sloan-Kettering  |  Wednesday, February 15, 2012

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan-Kettering.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Pictured: Memorial Sloan-Kettering logo
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Pictured: Charles Sawyers & Howard Scher
In the News
By Media Staff  |  Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.